Metoperil AT 50 Tablet contains Metoprolol Succinate 50mg + Amlodipine 5mg + Telmisartan 40mg, a combination medicine used for management of hypertension and cardiovascular risk reduction. It helps control blood pressure and supports overall heart health.
Metoprolol acts as a beta-blocker, reducing heart rate and cardiac workload, Amlodipine is a calcium channel blocker that relaxes blood vessels, and Telmisartan is an angiotensin receptor blocker that further reduces blood pressure. Together, they provide comprehensive cardiac protection.
This tablet is commonly prescribed for patients with moderate to severe hypertension or high cardiovascular risk, offering effective blood pressure control and improved compliance due to the combination formulation.
Metoperil AT 50 Tablet is valued for its triple-action mechanism, proven efficacy in cardiac management, and consistent clinical performance, making it a trusted option for hospitals, clinics, and cardiac care programs.
Common side effects may include dizziness, fatigue, headache, flushing, palpitations, or mild swelling of the ankles. Less common but serious side effects include hypotension, bradycardia, heart block, or kidney function changes. Patients should report any severe or persistent symptoms to their doctor promptly.
Metoperil AT 50 Tablet is indicated for the management of essential hypertension, alone or in combination therapy, especially in patients requiring multiple mechanisms for blood pressure control. It may also be beneficial in patients with cardiovascular risk factors such as diabetes or heart disease.
Metoperil AT 50 Tablet should be taken exactly as prescribed, preferably at the same time each day. Regular monitoring of blood pressure, heart rate, and kidney function is advised. Do not stop the medication abruptly without consulting a healthcare professional, as it may worsen heart conditions.
Store Metoperil AT 50 Tablet in a cool, dry place, away from sunlight and moisture. Keep out of reach of children and do not use after the expiry date indicated on the packaging.